Ur24Technology, DemeTECH Forge Surgical Product Partnership

Ur24Technology Inc. teaming up with DemeTECH Corporation to globally manufacture and distribute its surgical products.

“This partnership combines the strength of each company to deliver on the core mission we share—to improve patient care through innovation, products, and a distribution network that reaches 132 countries,” Ur24Technology Inc. CEO Landon Duval said. 
 
The partnership announcement follows the market lauch of Ur24Technology’s new external catheter, which was originally created to save a friend of Duval’s who was suffering from prostate enlargement nocturia. Duval researched, designed, and developed five different prototypes before his idea became a reality. 

Under the partnership’s terms, DemeTECH will manufacture Ur24Technology’s new external catheters and have exclusive worldwide distribution rights and non-exclusive U.S. distribution right. Products will be dually branded to facilitate smooth distribution worldwide.
 
“DemeTECH is proud to partner with Ur24Technology and step into the future of catheter systems with a brand new, made-in-the-USA external catheter for use with adults and pediatrics,” DemeTECH President Luis Arguello Jr. said. “Featuring safety, heightened prevention of catheter-associated urinary tract infections (CAUTIs), extended life, portability, ease-of-use and low cost, the Ur24 external catheter will improve patient outcomes by revolutionizing care.”
 
Ur24Technology is a privately held medical device company in southern California that Duval founded in 2016. 
 
Headquartered in Miami, DemeTECH, is a developer of surgical sutures, mesh and bone wax. DemeTECH’s N95 masks and dually branded external catheters are made in the United States.